CIK: 1029609 - Address: 222 South Mill Avenue, Suite 800, Tempe, AZ 85281
25 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

P%ret219-1-1-7-17-20-24-12
P%wins78564433334448
S%ret2112-1-1-7-10-10-4-5
S%wins58678367674264

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

10/9/07 12:50
10/4/07
LLNWLimelight Networks, Inc.DEBizSvBizSvBusiness ServicesGleberman Joseph HNYDP69.7181030,273I-50344122213-6-3-50-73-82
7/18/07 21:11
7/11/07
LLNWLimelight Networks, Inc.DEBizSvBizSvBusiness ServicesGleberman Joseph HNYDS-223.05180030,273I9-12-1505-49-31-54-67
7/18/07 21:11
7/16/07
LLNWLimelight Networks, Inc.DEBizSvBizSvBusiness ServicesGleberman Joseph HNYDP820.43180030,273I9-12-1505-49-31-54-67
6/26/07 16:37
6/8/07
LLNWLimelight Networks, Inc.DEBizSvBizSvBusiness ServicesGleberman Joseph HNYDP222.50180030,272I-9-9-470-49-57-78
6/26/07 16:37
6/12/07
LLNWLimelight Networks, Inc.DEBizSvBizSvBusiness ServicesGleberman Joseph HNYDS-119.81180030,272I-9-9-470-49-57-78
11/21/05 18:27
11/16/05
MCGCMcG Capital CorpFundCEFClosed-End FundsGleberman Joseph HNYHFormer DS.m-36915.326-24-21,343I2-6-1-14-7-700-3-2-461140
11/16/05 20:14
11/11/05
MCGCMcG Capital CorpFundCEFClosed-End FundsGleberman Joseph HNYHFormer DS.m-1,13715.307-74-51,367I2-71-13-8-6501-1-110841
9/16/05 16:30
9/14/05
MCGCMcG Capital CorpFundCEFClosed-End FundsGleberman Joseph HNYHFormer DS-417.626001,441I3010187-1-3-4-31-4-12-17-153
9/16/05 16:30
9/15/05
MCGCMcG Capital CorpFundCEFClosed-End FundsGleberman Joseph HNYHFormer DP1917.626101,441I3010187-1-3-4-31-4-12-17-153
9/15/05 17:16
9/13/05
MCGCMcG Capital CorpFundCEFClosed-End FundsGleberman Joseph HNYHFormer DS-2017.756-101,440I32102070-2-4-21-2-9-14-134
9/12/05 18:55
9/8/05
MCGCMcG Capital CorpFundCEFClosed-End FundsGleberman Joseph HNYHFormer DS-10,99818.336-600-291,441I3411201103-1-2-2-2-9-19-160
7/7/05 15:32
5/25/05
MCGCMcG Capital CorpFundCEFClosed-End FundsGleberman Joseph HNYDP3615.949204,041I342471592211140-122
6/23/05 16:37
6/22/05
MCGCMcG Capital CorpFundCEFClosed-End FundsGleberman Joseph HNYDS-33,00016.507-2,000-502,039I3320814133022385-93
12/8/04 14:16
11/29/04
MCGCMcG Capital CorpFundCEFClosed-End FundsGleberman Joseph HNYDP.a2317.755104,039I88-39-5-4-7-7-410406-5
12/1/04 19:39
11/29/04
MCGCMcG Capital CorpFundCEFClosed-End FundsGleberman Joseph HNYDS-34,30017.154-2,000-334,038I10041511-1-3-41-30-40-4
4/26/04 16:23
4/20/04
MCGCMcG Capital CorpFundCEFClosed-End FundsGleberman Joseph HNYDS-117.923006,038I168012-10-8-12-10-7-8-9-641
4/26/04 16:23
4/22/04
MCGCMcG Capital CorpFundCEFClosed-End FundsGleberman Joseph HNYDP117.623006,038I168012-10-8-12-10-7-8-9-641
2/20/04 17:05
2/3/04
MCGCMcG Capital CorpFundCEFClosed-End FundsGleberman Joseph HNYDS-1120.253-106,038I59147271923-2-20-2-7-19-11-6
2/20/04 17:05
2/4/04
MCGCMcG Capital CorpFundCEFClosed-End FundsGleberman Joseph HNYDP1120.083106,038I59147271923-2-20-2-7-19-11-6
11/17/03 18:51
11/13/03
AAIIAaipharma IncDEHealthBiolabTesting LaboratoriesGleberman Joseph HNYDS.d-819.150003,415I
11/17/03 18:51
11/14/03
AAIIAaipharma IncDEHealthBiolabTesting LaboratoriesGleberman Joseph HNYDP.d819.210003,415I
10/27/03 21:02
10/23/03
AAIIAaipharma IncDEHealthBiolabTesting LaboratoriesGleberman Joseph HNYDP8817.560503,415I
10/27/03 21:02
10/23/03
AAIIAaipharma IncDEHealthBiolabTesting LaboratoriesGleberman Joseph HNYDS-8817.560-503,415I
10/3/03 20:06
10/1/03
MCGCMcG Capital CorpFundCEFClosed-End FundsGleberman Joseph HNYDP1616.073106,038I497754-1-23027232918
10/3/03 20:06
10/1/03
MCGCMcG Capital CorpFundCEFClosed-End FundsGleberman Joseph HNYDS-1616.143-106,038I497754-1-23027232918

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact